Windtree Therapeutics Stock Forecast - 4 Period Moving Average
| WINT Stock | USD 0.02 0.0002 1.01% |
The 4 Period Moving Average forecasted value of Windtree Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.32. Windtree Stock Forecast is based on your current time horizon.
At this time the rsi of Windtree Therapeutics' share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (486.50) | Wall Street Target Price 4 | Quarterly Revenue Growth (1.00) |
Using Windtree Therapeutics hype-based prediction, you can estimate the value of Windtree Therapeutics from the perspective of Windtree Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The 4 Period Moving Average forecasted value of Windtree Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.32. Windtree Therapeutics after-hype prediction price | USD 0.014 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Windtree Therapeutics to cross-verify your projections. Windtree Therapeutics Additional Predictive Modules
Most predictive techniques to examine Windtree price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Windtree using various technical indicators. When you analyze Windtree charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Windtree Therapeutics 4 Period Moving Average Price Forecast For the 24th of January
Given 90 days horizon, the 4 Period Moving Average forecasted value of Windtree Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000059, and the sum of the absolute errors of 0.32.Please note that although there have been many attempts to predict Windtree Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Windtree Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Windtree Therapeutics Stock Forecast Pattern
| Backtest Windtree Therapeutics | Windtree Therapeutics Price Prediction | Buy or Sell Advice |
Windtree Therapeutics Forecasted Value
In the context of forecasting Windtree Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Windtree Therapeutics' downside and upside margins for the forecasting period are 0.0002 and 10.15, respectively. We have considered Windtree Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Windtree Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Windtree Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 101.0246 |
| Bias | Arithmetic mean of the errors | 0.0036 |
| MAD | Mean absolute deviation | 0.0055 |
| MAPE | Mean absolute percentage error | 0.1193 |
| SAE | Sum of the absolute errors | 0.3153 |
Predictive Modules for Windtree Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Windtree Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Windtree Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Windtree Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Windtree Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Windtree Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Windtree Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Windtree Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Windtree Therapeutics' historical news coverage. Windtree Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 10.14, respectively. We have considered Windtree Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Windtree Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Windtree Therapeutics is based on 3 months time horizon.
Windtree Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Windtree Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Windtree Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Windtree Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.36 | 10.13 | 0.05 | 0.68 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.02 | 0.01 | 29.76 |
|
Windtree Therapeutics Hype Timeline
Windtree Therapeutics is at this time traded for 0.02. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of -0.68. Windtree is estimated to decline in value after the next headline, with the price expected to drop to 0.014. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -29.76%, whereas the daily expected return is at this time at -2.36%. The volatility of related hype on Windtree Therapeutics is about 3517.36%, with the expected price after the next announcement by competition of -0.66. The company has Price to Book (P/B) ratio of 0.61. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Windtree Therapeutics recorded earning per share (EPS) of 62.6. The entity last dividend was issued on the 29th of April 2020. The firm had 1:50 split on the 21st of February 2025. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out Historical Fundamental Analysis of Windtree Therapeutics to cross-verify your projections.Windtree Therapeutics Related Hype Analysis
Having access to credible news sources related to Windtree Therapeutics' direct competition is more important than ever and may enhance your ability to predict Windtree Therapeutics' future price movements. Getting to know how Windtree Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Windtree Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| REVB | Revelation Biosciences | 0.03 | 11 per month | 0.00 | (0.16) | 5.56 | (8.33) | 20.39 | |
| DRMA | Dermata Therapeutics | (0.32) | 9 per month | 0.00 | (0.12) | 13.85 | (10.23) | 37.70 | |
| ATXI | Avenue Therapeutics | (0.64) | 10 per month | 0.00 | (0.09) | 12.66 | (17.20) | 42.40 | |
| XRTX | XORTX Therapeutics | (0.01) | 10 per month | 0.00 | (0.07) | 7.27 | (8.33) | 61.23 | |
| VRAX | Virax Biolabs Group | 0.03 | 7 per month | 0.00 | (0.08) | 8.20 | (10.20) | 92.80 | |
| AIMD | Ainos Inc | 0.04 | 10 per month | 0.00 | (0.20) | 6.71 | (9.79) | 28.00 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 0.00 | 0.21 | 37.84 | (6.00) | 126.82 | |
| NCEL | NewcelX | 0.59 | 5 per month | 0.00 | (0.26) | 10.12 | (16.98) | 39.40 | |
| GTBP | GT Biopharma | 0.04 | 9 per month | 6.87 | 0.03 | 10.84 | (10.45) | 51.03 | |
| ELAB | Elevai Labs Common | (2.64) | 5 per month | 0.00 | (0.46) | 4.32 | (14.29) | 38.62 |
Other Forecasting Options for Windtree Therapeutics
For every potential investor in Windtree, whether a beginner or expert, Windtree Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Windtree Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Windtree. Basic forecasting techniques help filter out the noise by identifying Windtree Therapeutics' price trends.Windtree Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Windtree Therapeutics stock to make a market-neutral strategy. Peer analysis of Windtree Therapeutics could also be used in its relative valuation, which is a method of valuing Windtree Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Windtree Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Windtree Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Windtree Therapeutics shares will generate the highest return on investment. By undertsting and applying Windtree Therapeutics stock market strength indicators, traders can identify Windtree Therapeutics entry and exit signals to maximize returns.
Windtree Therapeutics Risk Indicators
The analysis of Windtree Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Windtree Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting windtree stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.41 | |||
| Standard Deviation | 10.95 | |||
| Variance | 119.9 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Windtree Therapeutics
The number of cover stories for Windtree Therapeutics depends on current market conditions and Windtree Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Windtree Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Windtree Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Windtree Therapeutics Short Properties
Windtree Therapeutics' future price predictability will typically decrease when Windtree Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Windtree Therapeutics often depends not only on the future outlook of the potential Windtree Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Windtree Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.6 K | |
| Cash And Short Term Investments | 1.8 M |
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.